No registrations found.
ID
Source
Brief title
Health condition
Multiple sclerosis (MS), Cognitive problems
Sponsors and support
Intervention
Outcome measures
Primary outcome
Subjective cognitive complaints
Secondary outcome
- Objective cognitive function (neuropsychological examination based on the Minimal Assessment of Cognitive Function in MS (MACFIMS)),
- Functional brain networks (magnetoencephalography (MEG)),
- Psychological symptoms (depression, anxiety, fatigue, rumination),
- Quality of life,
- Well-being (the ability to be mindful, self-compassion, and emotional, psychological and social well-being),
- Daily life functioning.
Background summary
The REMIND-MS study is a dual-centre randomised controlled trail (RCT) that will primarily investigate the effect of cognitive rehabilitation therapy (CRT) and mindfulness-based cognitive therapy (MBCT) on subjectively experienced cognitive problems among MS patients. The study will also investigate the effect of CRT and MBCT on the secondary outcome measures, and we will investigate which factors predict a beneficial effect of the interventions.
Furthermore, resting-state magnetoencephalography (MEG) data will be obtained to gain additional knowledge about the aetiology of subjective and objective cognitive problems with respect to functional brain networks, and to explore the role of functional brain network changes in the effect of the interventions.
In addition, it will be evaluated whether alterations in the secondary outcome measures are mediating factors that determine subjective cognitive function.
Study objective
We hypothesize that both cognitive rehabilitation therapy (CRT) and mindfulness-based cognitive therapy (MBCT) positively affect the primary outcome measure subjective cognitive function compared to enhanced treatment as usual (ETAU). Secondarily, we expect positive effects on the secondary outcome measures objective cognitive functioning, functional brain network measures, psychological symptoms, well-being, quality of life and daily life functioning. Additionally, we will exploratory evaluate whether there are differences in intervention effects between CRT and MBCT.
Study design
Baseline, post-intervention, 6-months follow-up
Intervention
Cognitive rehabilitation therapy (CRT) and mindfulness-based cognitive therapy (MBCT).
Control condition: enhanced treatment as usual (ETAU).
I.M. Nauta
Boelelaan 1117
Amsterdam 1081 HV
The Netherlands
i.nauta1@vumc.nl
I.M. Nauta
Boelelaan 1117
Amsterdam 1081 HV
The Netherlands
i.nauta1@vumc.nl
Inclusion criteria
Participants are eligible to participate if they meet the following criteria:
(1) between 18 and 65 years of age,
(2) confirmed MS according to the McDonald 2010 criteria,
(3) a minimum score of 23 on the Multiple Sclerosis Neuropsychological Questionnaire – Patient version (MSNQ-P), which measures subjective cognitive complaints.
Exclusion criteria
Participants who meet any of the following criteria are excluded from participation:
(1) psychosis,
(2) suicidal ideation,
(3) an inability to speak or read Dutch,
(4) previous experience with a similar intervention,
(5) physical or cognitive disabilities, comorbidities or treatments that would interfere too much with the interventions to enrol in this study (to be evaluated on an individual level).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6285 |
| NTR-old | NTR6459 |
| Other | CWO-nr. 16-14 : METC 2017.009 |